Abbvie Inc

NYSE:ABBV   3:59:59 PM EDT
83.95
-0.39 (-0.46%)
4:00:00 PM EDT: $83.91 -0.04 (-0.05%)
Products

Abbvie Says Venclexta Receives FDA Full Approval For Acute Myeloid Leukemia

Published: 10/16/2020 23:48 GMT
AbbVie Inc (ABBV) - Venclexta® (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (aml).